NCT03749616

Brief Summary

Non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, are excellent medications for providing pain control in certain patients. There is some data to suggest that NSAIDs can be used to reduce postoperative pain and narcotic use in patients who had undergone carpal tunnel release. There are mixed results about the effect of bone healing in adult patients with broken bones. The investigators hypothesize that NSAID administration in the acute phase of distal radius fracture healing will be non-inferior for pain control and decrease the use of opioid analgesics compared to patients who take acetaminophen for pain control during this same time period. Furthermore, the investigators hypothesize that patients will have similar or better patient reported outcomes, range of motion, and strength with the administration of NSAIDs.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jan 2019

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 21, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

January 2, 2019

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 24, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 24, 2022

Completed
2.5 years until next milestone

Results Posted

Study results publicly available

September 5, 2024

Completed
Last Updated

September 5, 2024

Status Verified

August 1, 2024

Enrollment Period

3.2 years

First QC Date

September 26, 2018

Results QC Date

December 18, 2023

Last Update Submit

August 14, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Number of Oxycodone Tablets Used for Breakthrough Pain.

    The number and dosing of oxycodone tablets taken per participant for breakthrough pain will be recorded.

    2 weeks

  • Intensity of Pain: Visual Analog Scale (VAS)

    The patient will be asked to report their pain on a scale of 0 - 10 using the Visual Analog Scale with 0 being no pain and 10 being the worst pain the patient can imagine.

    2 Week, 6 Week, 3 Month, 6 Month and 1 Year Post Surgery

  • Fractures Fully Healed

    Radiographic evidence of boney healing of the distal radius. This outcome measure is reported as the number of participants in each group with fully healed fractures at the designated time point.

    6 weeks post surgery

Secondary Outcomes (5)

  • QuickDASH

    2 Week, 6 Week, 3 Month, 6 Month and 1 Year Post Surgery

  • Patient Reported Outcomes Measurement Information System (PROMIS) - UE (Upper Extremity)

    2 Weeks, 6 Weeks, 3 Months, 6 Months and 1 Year post surgery

  • Grip Strength

    2 Week, 6 Week and 3 Month Post Surgery

  • Key Pinch Strength

    2 weeks, 6 weeks, and 3 months post surgery

  • Wrist Range of Motion (ROM)

    2 weeks, 6 weeks and 3 months post surgery

Study Arms (2)

Acetaminophen

ACTIVE COMPARATOR

Acetaminophen for pain control with dose and frequency of 325mg 1-2 tablets q4-6h hours as needed, Maximum dose 1000mg. Maximum amount per day: 3g/day. Oxycodone 5mg 1-2 tablets q4-6 hours will be available as needed for breakthrough pain.

Drug: Acetaminophen

NSAID

EXPERIMENTAL

NSAID administered ibuprofen 400-800 mg, up to three times a day and acetaminophen with dose and frequency of 325mg 1-2 tablets q4-6h hours as needed, Maximum dose 1000mg. Maximum amount per day: 3g/day as needed for pain control. Oxycodone 5mg 1-2 tablets q4-6 hours will be available for breakthrough pain.

Drug: Ibuprofen

Interventions

NSAID Group - will be administered ibuprofen 400-800 mg, up to three times a day as needed for pain control

Also known as: Motrin, Advil
NSAID

Control Group - will be administered acetaminophen for pain control with dose and frequency of 325mg 1-2 tablets q4-6h hours as needed, Maximum dose 1000mg. Maximum amount per day: 3g/day.

Also known as: tylenol
Acetaminophen

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18
  • Distal radius fracture

You may not qualify if:

  • Contraindication to NSAID use (ie, cannot tolerate, gastritis, ulcers, chronic kidney disease stage 4 or higher, bleeding disorders/thrombocytopenia)
  • Inability to take breakthrough medications
  • Regular use of NSAIDs
  • Regular use of Narcotics
  • Open fracture
  • Other orthopaedic injuries (polytrauma)
  • Pathologic fracture
  • Previous injury to the bone
  • Pregnant or plan to become pregnant
  • Unable to sign informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Missouri Health Care

Columbia, Missouri, 65212, United States

Location

MeSH Terms

Conditions

Wrist Fractures

Interventions

IbuprofenAcetaminophen

Condition Hierarchy (Ancestors)

Wrist InjuriesArm InjuriesWounds and InjuriesFractures, Bone

Intervention Hierarchy (Ancestors)

PhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic ChemicalsAcetanilidesAnilidesAmidesAniline CompoundsAmines

Results Point of Contact

Title
Vicki L Jones
Organization
UMissouri

Study Officials

  • Daniel A London, MD

    University of Missouri-Columbia

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor, Orthopedic Surgery

Study Record Dates

First Submitted

September 26, 2018

First Posted

November 21, 2018

Study Start

January 2, 2019

Primary Completion

March 24, 2022

Study Completion

March 24, 2022

Last Updated

September 5, 2024

Results First Posted

September 5, 2024

Record last verified: 2024-08

Locations